Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | President, Nobel Biocare | August 25, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date August 25, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,560 |
Reported balance
After 2026-08-25 transaction · row 1
1 source rowRow 1 · 2026-08-25 · Tax withholding · Disposed 804 · Balance 61,560 F1: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 20:19 UTC | Envista Holdings Corp NVST · Entity 4007 | Tax withholdingCommon Stock | 804 | $27.47 | $22,085.88 |
DisclosureSEC source: 0002045818-26-000005 · wk-form4_1787861937.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,560 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantEmployee Stock Option (Right to Buy) · Derivative | 18,020 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 4 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,020 Underlying: Common Stock · 18,020 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantPerformance Share Unit · Derivative | 13,845 | $0.00 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 3 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,845 Underlying: Common Stock · 13,845 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 7,605 | $0.00 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 2 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,364 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC | Envista Holdings Corp NVST · Entity 4007 | Tax withholdingCommon Stock | 182 | $29.59 | $5,385.38 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,759 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:15 UTC | Envista Holdings Corp NVST · Entity 4007 | Tax withholdingCommon Stock | 804 | $21.12 | $16,980.48 |
DisclosureSEC source: 0002045818-25-000003 · wk-form4_1756325732.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,941 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,010 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 3 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 Underlying: Common Stock · 24,010 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantPerformance Share Unit · Derivative | 18,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 2 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,960 Underlying: Common Stock · 18,960 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,745 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.